Institutional isotretinoin settlement forecasting. Solve for IBD liability, surgical recovery potentials, and diagnosis timing arbitrage.
MDL DATA
2026 Statutory Sync
| Metric | Verification |
|---|---|
| Litigation Status | Active Litigation |
| Main Issue | IBD / Depression |
| Total Settlements | $150M+ Total |
| Injury Class | Avg Settlement |
|---|---|
| Crohn's Disease | $350,000 |
| Ulcerative Colitis | $300,000 |
| Depression / Suicidal Ideation | $250,000 |
| Birth Defects | $500,000 |
| Factor | Multiplier |
|---|---|
| Surgical Intervention | 1.4x |
| Birth Defect Exposure | 5.0x Base |
| Audit Version | S-Class v2.6 |
Accutane (Isotretinoin) liability is governed by **Systemic Inflammatory Loops**. Our engine audits recovery potentials based on documented surgical costs (colectomy), diagnosis timelines relative to therapy, and current medical liability protocols.
Audit of diagnosis proximity to usage
Surgery & ongoing treatment audit
Isotretinoin dosage & duration logic
"Calibrated against 2026 FDA pharmacovigilance reports, Multi-District Litigation (MDL) settlement trends, and gastrointestinal clinical liability benchmarks."
A: Accutane lawsuits allege that the drug causes Systemic Inflammatory conditions, specifically Crohn's disease and Ulcerative Colitis, and that manufacturers failed to adequately warn patients of these permanent risks.
A: Individuals who took isotretinoin and developed IBD, Crohn's, Ulcerative Colitis, or psychiatric effects may qualify. Discovery rules may extend filing deadlines even if the drug was taken years ago.
A: Settlement values for 2026 are heavily dependent on diagnosis severity. Cases involving surgical intervention for IBD typically receive higher projected recoveries ranging from $350k to over $500k.
Don't suffer in silence from medical negligence. Initiate your official S-Class forensic Accutane injury audit.
INITIATE AUDIT NOW